Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

New Covid variant with ‘high number of mutations’ found in UK

Health officials said the BA.2.86 mutation was detected in the UK on Friday.

Gwyn Wright
Friday 18 August 2023 16:31 EDT
The UKHSA said it would continue to monitor the spread of the Covid variant closely (Yui Mok/PA)
The UKHSA said it would continue to monitor the spread of the Covid variant closely (Yui Mok/PA) (PA Archive)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

A new coronavirus variant with a “high number of mutations” has been detected in the UK.

The BA.2.86 mutation was identified in the UK on Friday in someone with no recent travel history, the UK Health Security Agency said.

This means there could already be “significant community transmission” among Britons, the agency added.

The strain was first detected in Denmark on July 24 and was also found in that country on July 31, the same day it was discovered in Israel.

A case in the US was detected earlier this month.

The variant is said to be gnomically distant from its likely ancestor the BA.2 variant, nicknamed “stealth Omicron”.

We are not expecting to witness comparable levels of severe disease and death than we did earlier in the pandemic when the Alpha, Delta or Omicron variants spread

Professor Francois Balloux, University College London

That variant gained its nickname from the fact it is more transmissible than the original Omicron strain, which originated in southern Africa and was first detected in the UK in late 2021.

The UKHSA said there is “insufficient data” to assess the new strain’s relative severity or how likely it is to evade the protection offered by vaccines compared to other currently-circulating variants.

The agency said it would continue to monitor the spread of the variant closely while checks to determine the risks it may pose continue.

Francois Balloux, Professor of computational systems biology and director of the UCL Genetics Institute at University College London, said the new strain is “the most striking SARS-CoV-2 strain the world has witnessed since the emergence of Omicron” with more than 30 mutations.

However it is unlikely to cause a fresh wave of severe disease and deaths, or prompt fresh restrictions on people’s daily lives, because most people have some immunity to the illness.

He said: “Even in the worst-case scenario where BA.2.86 caused a major new wave of cases, we are not expecting to witness comparable levels of severe disease and death than we did earlier in the pandemic when the Alpha, Delta or Omicron variants spread.

“Most people on Earth have now been vaccinated and/or infected by the virus.

“Even if people get reinfected by BA.2.86, immune memory will still allow their immune system to kick in and control the infection far more effectively.

“It remains that a large wave of infection by BA.2.86, or any future comparable variant, would be an unwelcome event.”

The strain is likely to have emerged in an immunocompromised person who later spread it, the professor added.

UKHSA deputy director Dr Meera Chand said: “V-23AUG-01 was designated as a variant on August 18 2023 on the basis of international transmission and significant mutation of the viral genome.

“This designation allows us to monitor it through our routine surveillance processes.

“We are aware of one confirmed case in the UK. UKHSA is currently undertaking detailed assessment and will provide further information in due course.”

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in